Burundi Eliminates Trachoma: A Public Health Success

Burundi Eliminates Trachoma as a public Health Problem, Marking⁣ a Meaningful Milestone in NTD fight

GENEVA – Burundi has achieved a⁣ monumental victory in global public health, officially eliminating trachoma as a public health problem. This significant accomplishment, announced by the World Health Organization (WHO), underscores the power of sustained commitment, strategic partnerships, and dedicated community efforts in combating neglected tropical diseases⁣ (NTDs).

“This is a remarkable achievement for Burundi and a testament to the⁤ country’s unwavering resolve to protect its most vulnerable populations,” stated Dr. Xavier Crespin, WHO Representative in Burundi. “Under the leadership of the Ministry of Public Health and the Fight Against AIDS, and with the dedication of community health workers, support from key partners, and ⁢WHO’s technical guidance, this success was made possible.This win inspires us to press forward with the same determination⁢ to eliminate all remaining neglected tropical diseases.”

Trachoma,a leading infectious cause of blindness worldwide,remains a significant public health challenge in 32 ⁤countries,affecting an estimated 103 million people in areas requiring interventions. ⁤It is indeed ⁢predominantly found in the ⁤poorest and most rural regions of‍ Africa, Central and South America, Asia, the Western Pacific, and the Middle East.

The African Region bears a disproportionate burden of trachoma,with 93 million people living in at-risk areas as of April 2024,accounting ⁢for 90% of the global burden. Despite this, considerable progress has been made. The number of people requiring antibiotic treatment for trachoma in the African Region ⁣has plummeted by 96 million, from 189 million in 2014 to 93 million in April 2024, representing a remarkable 51% reduction.

Currently, 20 countries within WHO’s African Region still require intervention for trachoma elimination. These include Algeria, Angola, Burkina Faso, Cameroon, Central African Republic, Chad, Côte d’Ivoire, Democratic Republic of ⁤the Congo, Eritrea, Ethiopia, Guinea, Kenya, Mozambique, Niger, Nigeria, South Sudan, United Republic of Tanzania, uganda, Zambia, and Zimbabwe. Seven countries in the region ‍have already been validated⁤ by WHO for eliminating trachoma as ‍a public health problem: Benin, Gambia, Ghana, Malawi, Mali, Mauritania, ⁣and Togo. Furthermore, ⁢four other countries in the WHO African Region – botswana, Guinea-Bissau, Namibia, and Senegal – have reported achieving the prevalence targets for elimination.With Burundi’s inclusion, a total of 57 countries have now successfully eliminated at least one NTD. Of these, 24 countries, including Burundi, ‍have achieved the critical milestone of eliminating trachoma as a ⁣public health problem. Other nations that have reached this significant benchmark include Benin, Cambodia, China, Gambia, Islamic Republic of Iran, Lao people’s Democratic Republic, Ghana, India, Iraq, Malawi, Mali, Mauritania, Mexico,‍ Morocco, Myanmar, Nepal, Oman,‍ Pakistan, Papua New Guinea, Saudi arabia, Togo, Vanuatu, and Viet Nam.

Defining Elimination:

Elimination of trachoma as a public⁤ health problem is defined by specific criteria:
A prevalence of trachomatous trichiasis (TT), the blinding stage of the disease, ⁢of less than 0.2% in adults aged 15 years and ⁤older (approximately 1 case per 1,000 total⁣ population) that is unknown to the health system.
A prevalence of trachomatous inflammation – follicular (TF) in children aged 1-9 years of ⁢less than 5%, sustained for at least two years in the‍ absence of ongoing mass antibiotic treatment, in each formerly endemic district.
⁣ The existence of a robust system capable of identifying and managing incident TT cases, utilizing defined strategies and demonstrating appropriate financial resources for their implementation.

The WHO’s SAFE strategy ⁢remains‍ the cornerstone of trachoma control and elimination efforts. This comprehensive approach includes:
Surgery to treat the blinding stage (trachomatous trichiasis).
Antibiotics to clear the infection, primarily through mass drug management of azithromycin, generously donated by Pfizer to elimination programs via the International Trachoma Initiative.
Facial⁤ cleanliness.
* Environmental improvement, with ‍a focus on enhancing access to water and sanitation.

Burundi’s success serves as a powerful beacon of hope, demonstrating that with concerted effort and global collaboration, the world can move closer to a future free from the burden of neglected tropical diseases.